Company: MLTX
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001140361-25-014923
Chunk: 26

Company: MoonLake Immunotherapeutics
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 26
---
 our non-employee directors other than Dr. Lassen received a grant of 7,688 share options on June 6, 2024 under the MoonLake Immunotherapeutics 2022 Equity Incentive Plan (the “Incentive Plan”) that vest in full on the earlier of (i) the one-year anniversary of the date of grant, (ii) the next annual general meeting of shareholders and (iii) the date of a Change of Control (as defined in the Incentive Plan), subject to continued service through such date. Dr. Lassen waived her right to receive such grant. Members of our Board are also eligible to receive reimbursement for reasonable travel and miscellaneous expenses incurred in attending meetings and activities of our Board and its committees. Additionally, directors who are also members of the board of directors of MoonLake AG (Messrs. Sturge and Loy and Dr. Phillips) are reimbursed for business expenses reasonably incurred in connection with such services. 2024 Non-Employee Director Compensation The following table summarizes information concerning the compensation awarded to, earned by and paid to the non-employee directors for services rendered to the Company for the year ended December 31, 2024.

| Name                 |     | Fees Earned or 
   Paid in Cash 
            ($) |     | Option Awards 
     ($)(1)(2) |     |    Total 
      ($) |
| Simon Sturge         |     |        $90,500 |     |      $225,005 |     | $315,505 |
| Dr. Kara Lassen(3)   |     |        $44,000 |     |             — |     |  $44,000 |
| Spike Loy(4)         |     |        $52,500 |     |      $225,005 |     | $277,505 |
| Catherine Moukheibir |     |        $62,500 |     |      $225,005 |     | $287,505 |
| Dr. Andrew Phillips  |     |        $56,000 |     |      $225,005 |     | $281,005 |
| Dr. Ramnik Xavier    |     |        $75,000 |     |      $225,005 |     | $300,005 |

| (1) | Amounts shown under the “Options Awards” column are calculated using the Black-Scholes option valuation model. While the amounts shown are computed in accordance with Financial Accounting Standards Board (“FASB”) Accounting